RB1 and ovarian carcinoma: Interestingly, compared with parental cells, ovarian cancer cells resistant to flavopiridol and cisplatin showed the increased expressions of CDK1, cyclin D3 and Rb, decreased expressions of cyclin B, and equal expressions of cyclin A, cyclin E, CDK2, CDK4 [44].